Suppr
超能文献

Mechanisms of anabolic therapies for osteoporosis.

作者信息

Canalis Ernesto, Giustina Andrea, Bilezikian John P

机构信息

Department of Research, Saint Francis Hospital and Medical Center, Hartford, CT 06105-1299, USA.

出版信息

N Engl J Med. 2007 Aug 30;357(9):905-16. doi: 10.1056/NEJMra067395.

DOI:10.1056/NEJMra067395

PMID:17761594

Abstract

摘要

相似文献

Mechanisms of anabolic therapies for osteoporosis.

N Engl J Med. 2007 Aug 30;357(9):905-16. doi: 10.1056/NEJMra067395.

Update in new anabolic therapies for osteoporosis.

J Clin Endocrinol Metab. 2010 Apr;95(4):1496-504. doi: 10.1210/jc.2009-2677.

New therapeutic targets for osteoporosis: beyond denosumab.

Maturitas. 2012 Nov;73(3):269-72. doi: 10.1016/j.maturitas.2012.08.002. Epub 2012 Aug 24.

Histomorphometric changes following treatment for osteoporosis.

J Endocrinol Invest. 2017 Sep;40(9):895-897. doi: 10.1007/s40618-017-0662-6. Epub 2017 May 26.

[Potential use of parathyroid hormone (PTH) in the treatments for oral diseases].

Clin Calcium. 2012 Jan;22(1):75-82.

New anabolic agents in the treatment of osteoporosis.

S Afr Med J. 2003 Oct;93(10):754-6.

The use of PTH in the treatment of osteoporosis.

Arq Bras Endocrinol Metabol. 2010 Mar;54(2):213-9. doi: 10.1590/s0004-27302010000200018.

Anabolic therapy in glucocorticoid-induced osteoporosis.

N Engl J Med. 2007 Nov 15;357(20):2084-6. doi: 10.1056/NEJMe0706770.

Anabolic agents and bone quality.

Clin Orthop Relat Res. 2011 Aug;469(8):2215-24. doi: 10.1007/s11999-010-1722-9.

Anabolic therapies for osteoporosis.

Endocrinol Metab Clin North Am. 2012 Sep;41(3):507-25. doi: 10.1016/j.ecl.2012.05.002. Epub 2012 Jun 20.

引用本文的文献

A three-stage assembly program governing pancreatic, plasma, pituitary, and bone secretory cell differentiation: A strategy to augment protein delivery.

J Biol Chem. 2025 Aug 5;301(9):110562. doi: 10.1016/j.jbc.2025.110562.

PTH stimulation of Rankl transcription is regulated by SIK2 and 3 and mediated by CRTC2 and 3 through action of protein phosphatases 1, 2, 4, and 5.

J Biol Chem. 2025 Jul 1;301(8):110434. doi: 10.1016/j.jbc.2025.110434.

Prolonged hypercalcemia induced by teriparatide: a case report and literature review.

Osteoporos Int. 2025 Jun 11. doi: 10.1007/s00198-025-07569-z.

Biomaterial-based strategies for bone cement: modulating the bone microenvironment and promoting regeneration.

J Nanobiotechnology. 2025 May 13;23(1):343. doi: 10.1186/s12951-025-03363-5.

Teriparatide-induced Sever Persistent Hypercalcemia in an Osteoporotic Patient: A Case Report and Literature Review.

Arch Bone Jt Surg. 2025;13(3):170-175. doi: 10.22038/ABJS.2024.80907.3690.

VGF and the VGF-derived peptide AQEE30 stimulate osteoblastic bone formation through the C3a receptor.

Exp Mol Med. 2025 Mar;57(3):637-651. doi: 10.1038/s12276-025-01419-y. Epub 2025 Mar 13.

Assessment of evidence for the off-label application of osteoanabolic drugs in fracture healing and spinal fusion.

J Bone Miner Metab. 2025 Mar;43(2):57-60. doi: 10.1007/s00774-025-01589-9. Epub 2025 Feb 18.

Signal integrator function of CXXC5 in Cancer.

Cell Commun Signal. 2025 Jan 14;23(1):25. doi: 10.1186/s12964-024-02005-x.

Pregnancy- and Lactation-Associated Osteoporosis: A Literature Review Based on a Clinical Case.

Cureus. 2024 Nov 2;16(11):e72889. doi: 10.7759/cureus.72889. eCollection 2024 Nov.

Novel approach to bone comorbidity in resistant acromegaly.

Pituitary. 2024 Dec;27(6):813-823. doi: 10.1007/s11102-024-01468-y. Epub 2024 Nov 21.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Mechanisms of anabolic therapies for osteoporosis.

N Engl J Med. 2007 Aug 30;357(9):905-16. doi: 10.1056/NEJMra067395.

Update in new anabolic therapies for osteoporosis.

J Clin Endocrinol Metab. 2010 Apr;95(4):1496-504. doi: 10.1210/jc.2009-2677.

New therapeutic targets for osteoporosis: beyond denosumab.

Maturitas. 2012 Nov;73(3):269-72. doi: 10.1016/j.maturitas.2012.08.002. Epub 2012 Aug 24.

Histomorphometric changes following treatment for osteoporosis.

J Endocrinol Invest. 2017 Sep;40(9):895-897. doi: 10.1007/s40618-017-0662-6. Epub 2017 May 26.

[Potential use of parathyroid hormone (PTH) in the treatments for oral diseases].

Clin Calcium. 2012 Jan;22(1):75-82.

New anabolic agents in the treatment of osteoporosis.

S Afr Med J. 2003 Oct;93(10):754-6.

The use of PTH in the treatment of osteoporosis.

Arq Bras Endocrinol Metabol. 2010 Mar;54(2):213-9. doi: 10.1590/s0004-27302010000200018.

Anabolic therapy in glucocorticoid-induced osteoporosis.

N Engl J Med. 2007 Nov 15;357(20):2084-6. doi: 10.1056/NEJMe0706770.

Anabolic agents and bone quality.

Clin Orthop Relat Res. 2011 Aug;469(8):2215-24. doi: 10.1007/s11999-010-1722-9.

Anabolic therapies for osteoporosis.

Endocrinol Metab Clin North Am. 2012 Sep;41(3):507-25. doi: 10.1016/j.ecl.2012.05.002. Epub 2012 Jun 20.

引用本文的文献

A three-stage assembly program governing pancreatic, plasma, pituitary, and bone secretory cell differentiation: A strategy to augment protein delivery.

J Biol Chem. 2025 Aug 5;301(9):110562. doi: 10.1016/j.jbc.2025.110562.

PTH stimulation of Rankl transcription is regulated by SIK2 and 3 and mediated by CRTC2 and 3 through action of protein phosphatases 1, 2, 4, and 5.

J Biol Chem. 2025 Jul 1;301(8):110434. doi: 10.1016/j.jbc.2025.110434.

Prolonged hypercalcemia induced by teriparatide: a case report and literature review.

Osteoporos Int. 2025 Jun 11. doi: 10.1007/s00198-025-07569-z.

Biomaterial-based strategies for bone cement: modulating the bone microenvironment and promoting regeneration.

J Nanobiotechnology. 2025 May 13;23(1):343. doi: 10.1186/s12951-025-03363-5.

Teriparatide-induced Sever Persistent Hypercalcemia in an Osteoporotic Patient: A Case Report and Literature Review.

Arch Bone Jt Surg. 2025;13(3):170-175. doi: 10.22038/ABJS.2024.80907.3690.

VGF and the VGF-derived peptide AQEE30 stimulate osteoblastic bone formation through the C3a receptor.

Exp Mol Med. 2025 Mar;57(3):637-651. doi: 10.1038/s12276-025-01419-y. Epub 2025 Mar 13.

Assessment of evidence for the off-label application of osteoanabolic drugs in fracture healing and spinal fusion.

J Bone Miner Metab. 2025 Mar;43(2):57-60. doi: 10.1007/s00774-025-01589-9. Epub 2025 Feb 18.

Signal integrator function of CXXC5 in Cancer.

Cell Commun Signal. 2025 Jan 14;23(1):25. doi: 10.1186/s12964-024-02005-x.

Pregnancy- and Lactation-Associated Osteoporosis: A Literature Review Based on a Clinical Case.

Cureus. 2024 Nov 2;16(11):e72889. doi: 10.7759/cureus.72889. eCollection 2024 Nov.

Novel approach to bone comorbidity in resistant acromegaly.

Pituitary. 2024 Dec;27(6):813-823. doi: 10.1007/s11102-024-01468-y. Epub 2024 Nov 21.

Suppr超能文献

Mechanisms of anabolic therapies for osteoporosis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译